Strattera and Sumatriptan succinate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera and Sumatriptan succinate. Common interactions include pain among females and anxiety among males.

The phase IV clinical study analyzes what interactions people who take Strattera and Sumatriptan succinate have. It is created by eHealthMe based on reports of 26 people who take Strattera and Sumatriptan succinate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 30, 2022

26 people who take Strattera and Sumatriptan succinate together, and have interactions are studied.


What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 28,395 Strattera users for its effectiveness, alternative drugs and more.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 7,930 Sumatriptan succinate users for its effectiveness, alternative drugs and more.

Number of Strattera and Sumatriptan succinate reports submitted per year:

Strattera and Sumatriptan succinate drug interactions.

Common Strattera and Sumatriptan Succinate drug interactions by gender *:

female:

  1. Pain
  2. Fatigue
  3. Blood pressure decreased
  4. Confusional state
  5. Gastric bypass
  6. Hallucination
  7. Head injury
  8. Loss of consciousness
  9. Memory impairment
  10. Muscle spasms

male:

  1. Anxiety
  2. Arthralgia
  3. Weight decreased
  4. Arthropathy
  5. Drug dependence
  6. Emotional distress
  7. Fall
  8. Musculoskeletal discomfort
  9. Ocular hyperaemia
  10. Overdose

Common Strattera and Sumatriptan Succinate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal pain upper
  2. Akathisia
  3. Disturbance in attention
  4. Drug ineffective
  5. Drug withdrawal syndrome
  6. Dyskinesia
  7. Flatulence
  8. Irritability
  9. Myoclonus
  10. Pain

20-29:

  1. Dizziness

30-39:

n/a

40-49:

  1. Abdominal distension
  2. Anxiety
  3. Deep vein thrombosis
  4. Emotional distress
  5. Euphoric mood
  6. Fatigue
  7. Injury
  8. Pain
  9. Pulmonary embolism
  10. Therapeutic response decreased

50-59:

  1. Blood pressure decreased
  2. Chronic kidney disease
  3. Pain
  4. Panic attack
  5. Tubulointerstitial nephritis
  6. Flushing
  7. Hyperparathyroidism secondary
  8. Renal failure
  9. Confusional state
  10. Gastric bypass

60+:

n/a

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 53.85%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 38.46%
  3. Thyroid Diseases: 2 people, 7.69%
  4. High Blood Cholesterol: 2 people, 7.69%
  5. Back Pain: 2 people, 7.69%
  6. Bladder Disorder: 2 people, 7.69%
  7. Constipation: 2 people, 7.69%
  8. Diabetes: 2 people, 7.69%
  9. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 7.69%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Sumatriptan succinate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Strattera and Sumatriptan succinate interactions:

Browse all drug interactions of Strattera and Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Strattera interactions:

Browse all interactions between Strattera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Sumatriptan succinate interactions:

Browse all interactions between Sumatriptan succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride and sumatriptan succinate (the active ingredients of Strattera and Sumatriptan succinate, respectively), and Strattera and Sumatriptan succinate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Strattera and Sumatriptan succinate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: